naproxen and tirzepatide Taking With Tirzepatide: Safety Guide Impurity in Some Compounded Tirzepatide

G Ingredients Water, Propanediol, Phenethyl Benzoate, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Titanium Dioxide (CI 77891), Dibutyl Adipate, Diethylamino Hydroxybenzoyl Hexyl Benzoate, Butyloctyl Salicylate, C12-15 Alkyl Benzoate, Dipropylene Glycol, Niacinamide, Isononyl Isononanoate, Snail Secretion Filtrate (3,000,000ppb), Caesalpinia Spinosa Fruit Extract, Buddleja Officinalis Flower Extract, Nelumbium Speciosum Flower Extract, Nymphaea Alba Flower Extract, Prunus Serrulata Flower Extract, Rosa Hybrid Flower Extract, Kappaphycus Alvarezii Extract, Sodium Hyaluronate, Pinus Pinaster Bark Extract, Ethylhexyl Triazone, Pentylene Glycol, Polyglyceryl-3 Methylglucose Distearate, Polysilicone-15, Silica, 1,2-Hexanediol, Poly C10-30 Alkyl Acrylate, Potassium Cetyl Phosphate, Stearic Acid, Palmitic Acid, Glyceryl Stearate, Hydroxyacetophenone, Aluminum Hydroxide, Polyhydroxystearic Acid, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Isododecane, Octyldodecanol, Tromethamine, Hydrogenated Lecithin, Vinyl Dimethicone/Methicone Silsesquioxane Crosspolymer, Dipotassium Glycyrrhizate, Polyglyceryl-2 Dipolyhydroxystearate, Polyglyceryl-4 Isostearate, Adenosine, Isopropyl Titanium Triisostearate, Sodium Polyacrylate, Sorbitan Isostearate, Butylene Glycol, Glycerin, Glyceryl Oleate, Caprylic/Capric Triglyceride, Lauryl Glucoside, Myristyl Glucoside, Polyglyceryl-6 Laurate, Tocopherol, Linolenic Acid, Polyglyceryl-10 Oleate, Polyglyceryl-10 Stearate, Ethylhexylglycerin, Glutathione (100ppb), Aluminum/Magnesium Hydroxide Stearate, Sodium Stearoyl Glutamate, 7-Dehydrocholesterol, Calcium Chloride, Palmitoyl Pentapeptide-4, Cetearyl Alcohol, C12-16 Alcohol, Disodium EDTA, Xanthan Gum, Potassium Sorbate, Fragrance, Iron Oxide Yellow (CI 77492), Iron Oxide Red (CI 77491) Ingredients are subject to change at manufacturers discretion

Epidemiologic data suggest that a sustained 5 mmHg reduction in systolic blood pressure correlates with approximately 10% lower risk of major cardiovascular events and 7% reduction in all-cause mortality, though it's important to note that cardiovascular outcome trials for tirzepatide are ongoing and definitive cardiovascular benefit has not yet been established

protecting the heart, kidney, and liver

| Clinically guided care, designed to maximize your weight loss journey: A GLP-1 program that balances US-based medical oversight with everyday support